Research Article
No access
Published Online: 7 November 2014

Elimination of Remaining Undifferentiated Induced Pluripotent Stem Cells in the Process of Human Cardiac Cell Sheet Fabrication Using a Methionine-Free Culture Condition

Publication: Tissue Engineering Part C: Methods
Volume 21, Issue Number 3

Abstract

Cardiac tissue engineering is a promising method for regenerative medicine. Although we have developed human cardiac cell sheets by integration of cell sheet-based tissue engineering and scalable bioreactor culture, the risk of contamination by induced pluripotent stem (iPS) cells in cardiac cell sheets remains unresolved. In the present study, we established a novel culture method to fabricate human cardiac cell sheets with a decreased risk of iPS cell contamination while maintaining viabilities of iPS cell-derived cells, including cardiomyocytes and fibroblasts, using a methionine-free culture condition. When cultured in the methionine-free condition, human iPS cells did not survive without feeder cells and could not proliferate or form colonies on feeder cells or in coculture with cells for cardiac cell sheet fabrication. When iPS cell-derived cells after the cardiac differentiation were transiently cultured in the methionine-free condition, gene expression of OCT3/4 and NANOG was downregulated significantly compared with that in the standard culture condition. Furthermore, in fabricated cardiac cell sheets, spontaneous and synchronous beating was observed in the whole area while maintaining or upregulating the expression of various cardiac and extracellular matrix genes. These findings suggest that human iPS cells are methionine dependent and a methionine-free culture condition for cardiac cell sheet fabrication might reduce the risk of iPS cell contamination.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861, 2007.
2.
Porrello E.R., Mahmoud A.I., Simpson E., Hill J.A., Richardson J.A., Olson E.N., and Sadek H.A. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078, 2011.
3.
Sekine H., Shimizu T., Sakaguchi K., Dobashi I., Wada M., Yamato M., Kobayashi E., Umezu M., and Okano T. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun 4, 1399, 2013.
4.
Sakaguchi K., Shimizu T., Horaguchi S., Sekine H., Yamato M., Umezu M., and Okano T. In vitro engineering of vascularized tissue surrogates. Sci Rep 3, 1316, 2013.
5.
Haraguchi Y., Shimizu T., Sasagawa T., Sekine H., Sakaguchi K., Kikuchi T., Sekine W., Sekiya S., Yamato M., Umezu M., and Okano T. Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat Protoc 7, 850, 2012.
6.
Nishida K., Yamato M., Hayashida Y., Watanabe K., Yamamoto K., Adachi E., Nagai S., Kikuchi A., Maeda N., Watanabe H., Okano T., and Tano Y. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 351, 1187, 2004.
7.
Ohki T., Yamato M., Ota M., Takagi R., Murakami D., Kondo M., Sasaki R., Namiki H., Okano T., and Yamamoto M. Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology 143, 582, 2012.
8.
Sawa Y., Miyagawa S., Sakaguchi T., Fujita T., Matsuyama A., Saito A., Shimizu T., and Okano T. Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case. Surg Today 42, 181, 2012.
9.
Sato M., Yamato M., Hamahashi K., Okano T., and Mochida J. Articular cartilage regeneration using cell sheet technology. Anat Rec (Hoboken) 297, 36, 2014.
10.
Kushida A., Yamato M., Konno C., Kikuchi A., Sakurai Y., and Okano T. Decrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surfaces. J Biomed Mater Res 45, 355, 1999.
11.
Matsuura K., Masuda S., Haraguchi Y., Yasuda N., Shimizu T., Hagiwara N., Zandstra P.W., and Okano T. Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials 32, 7355, 2011.
12.
Matsuura K., Wada M., Shimizu T., Haraguchi Y., Sato F., Sugiyama K., Konishi K., Shiba Y., Ichikawa H., Tachibana A., Ikeda U., Yamato M., Hagiwara N., and Okano T. Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun 425, 321, 2012.
13.
Matsuura K., Haraguchi Y., Shimizu T., and Okano T. Cell sheet transplantation for heart tissue repair. J Control Release 169, 336, 2013.
14.
Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.S., Yuasa S., Li W., Yamakawa H., Tanaka T., Onitsuka T., Shimoji K., Ohno Y., Egashira T., Kaneda R., Murata M., Hidaka K., Morisaki T., Sasaki E., Suzuki T., Sano M., Makino S., Oikawa S., and Fukuda K. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7, 61, 2010.
15.
Dubois N.C., Craft A.M., Sharma P., Elliott D.A., Stanley E.G., Elefanty A.G., Gramolini A., and Keller G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 29, 1011, 2011.
16.
Uosaki H., Fukushima H., Takeuchi A., Matsuoka S., Nakatsuji N., Yamanaka S., and Yamashita J.K. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 6, e23657, 2011.
17.
Tohyama S., Hattori F., Sano M., Hishiki T., Nagahata Y., Matsuura T., Hashimoto H., Suzuki T., Yamashita H., Satoh Y., Egashira T., Seki T., Muraoka N., Yamakawa H., Ohgino Y., Tanaka T., Yoichi M., Yuasa S., Murata M., Suematsu M., and Fukuda K. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127, 2013.
18.
Cavuoto P., and Fenech M.F. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat Rev 38, 726, 2012.
19.
Haberkorn U., Markert A., Mier W., Askoxylakis V., and Altmann A. Molecular imaging of tumor metabolism and apoptosis. Oncogene 30, 4141, 2011.
20.
Halpern B.C., Clark B.R., Hardy D.N., Halpern R.M., and Smith R.A. The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci U S A 71, 1133, 1974.
21.
Ben-David U., and Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11, 268, 2011.
22.
Matsuura K., Honda A., Nagai T., Fukushima N., Iwanaga K., Tokunaga M., Shimizu T., Okano T., Kasanuki H., Hagiwara N., and Komuro I. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119, 2204, 2009.
23.
Matsuura K., Wada M., Konishi K., Sato M., Iwamoto U., Sato Y., Tachibana A., Kikuchi T., Iwamiya T., Shimizu T., Yamashita J.K., Yamato M., Hagiwara N., and Okano T. Fabrication of mouse embryonic stem cell-derived layered cardiac cell sheets using a bioreactor culture system. PLoS One 7, e52176, 2012.
24.
Matsuura K., Masuda S., and Shimizu T. Cell sheet-based cardiac tissue engineering. Anat Rec (Hoboken) 297, 65, 2014.
25.
Finkelstein J.D. Methionine metabolism in mammals. J Nutr Biochem 1, 228, 1990.
26.
Behrmann I., Wallner S., Komyod W., Heinrich P.C., Schuierer M., Buettner R., and Bosserhoff A.K. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 163, 683, 2003.
27.
Christopher S.A., Diegelman P., Porter C.W., and Kruger W.D. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 62, 6639, 2002.
28.
Yu J., Batova A., Shao L., Carrera C.J., and Yu A.L. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (−) malignancies. Clin Cancer Res 3, 433, 1997.
29.
Liau B., Christoforou N., Leong K.W., and Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 32, 9180, 2011.
30.
Sekine H., Shimizu T., Dobashi I., Matsuura K., Hagiwara N., Takahashi M., Kobayashi E., Yamato M., and Okano T. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A 17, 2973, 2011.
31.
Matsuura K., Shimizu T., and Okano T. Toward the development of bioengineered human three-dimensional vascularized cardiac tissue using cell sheet technology. Int Heart J 55, 1, 2014.
32.
Sakai H., Doi Y., Okano T., Yamada N., Sakurai Y. Thermo-responsive polymer surfaces for cell culture: analysis of the surfaces and control of the cell attachment/detachment. In: Ogata N., Kim S.W., Feijen J., and Okano T., eds. Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems. Tokyo: Springer-Verlag, 1996, p. 229.
33.
Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., and Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101, 2008.
34.
Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., Hong H., Nakagawa M., Tanabe K., Tezuka K., Shibata T., Kunisada T., Takahashi M., Takahashi J., Saji H., and Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409, 2011.
35.
Shiraki N., Shiraki Y., Tsuyama T., Obata F., Miura M., Nagae G., Aburatani H., Kume K., Endo F., and Kume S. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab 19, 780, 2014.

Information & Authors

Information

Published In

cover image Tissue Engineering Part C: Methods
Tissue Engineering Part C: Methods
Volume 21Issue Number 3March 2015
Pages: 330 - 338
PubMed: 25245976

History

Published in print: March 2015
Published ahead of print: 11 November 2014
Published online: 7 November 2014
Published ahead of production: 23 September 2014
Accepted: 3 September 2014
Received: 10 April 2014

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Katsuhisa Matsuura
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
Fumiko Kodama
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Kasumi Sugiyama
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Tatsuya Shimizu
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Nobuhisa Hagiwara
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
Teruo Okano
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.

Notes

Address correspondence to:Katsuhisa Matsuura, MD, PhDInstitute of Advanced Biomedical Engineering and ScienceTokyo Women's Medical University8-1 Kawada-choShinjukuTokyo 162-8666Japan
E-mail: [email protected]

Disclosure Statement

Teruo Okano is a founder and director of the board of Cell Seed, Inc., licensing technologies and patents from Tokyo Women's Medical University. Teruo Okano and Tatsuya Shimizu are stakeholders of Cell Seed, Inc. Tokyo Women's Medical University is receiving research funds from CellSeed, Inc. Teruo Okano, Tatsuya Shimizu, and Katsuhisa Matsuura are inventors of bioreactor systems.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top